154 related articles for article (PubMed ID: 33992469)
1. Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives.
Serapian SA; Sanchez-MartÃn C; Moroni E; Rasola A; Colombo G
Trends Pharmacol Sci; 2021 Jul; 42(7):566-576. PubMed ID: 33992469
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.
Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G
Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652
[TBL] [Abstract][Full Text] [Related]
3. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
[No Abstract] [Full Text] [Related]
4. The Mitochondrial HSP90 Paralog TRAP1: Structural Dynamics, Interactome, Role in Metabolic Regulation, and Inhibitors.
Joshi A; Ito T; Picard D; Neckers L
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883436
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis.
Joshi A; Dai L; Liu Y; Lee J; Ghahhari NM; Segala G; Beebe K; Jenkins LM; Lyons GC; Bernasconi L; Tsai FTF; Agard DA; Neckers L; Picard D
BMC Biol; 2020 Jan; 18(1):10. PubMed ID: 31987035
[TBL] [Abstract][Full Text] [Related]
6. TRAP1: a viable therapeutic target for future cancer treatments?
Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
[TBL] [Abstract][Full Text] [Related]
7. TRAP1 Chaperones the Metabolic Switch in Cancer.
Wengert LA; Backe SJ; Bourboulia D; Mollapour M; Woodford MR
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740911
[TBL] [Abstract][Full Text] [Related]
8. Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes.
Triveri A; Sanchez-Martin C; Torielli L; Serapian SA; Marchetti F; D'Acerno G; Pirota V; Castelli M; Moroni E; Ferraro M; Quadrelli P; Rasola A; Colombo G
J Mol Biol; 2022 Sep; 434(17):167468. PubMed ID: 35101454
[TBL] [Abstract][Full Text] [Related]
9. New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments.
Li XT; Li YS; Shi ZY; Guo XL
Life Sci; 2020 Aug; 254():117737. PubMed ID: 32376268
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial chaperone, TRAP1 as a potential pharmacological target to combat cancer metabolism.
Ramkumar B; Dharaskar SP; Mounika G; Paithankar K; Sreedhar AS
Mitochondrion; 2020 Jan; 50():42-50. PubMed ID: 31669620
[TBL] [Abstract][Full Text] [Related]
11. Dynamics-based community analysis and perturbation response scanning of allosteric interaction networks in the TRAP1 chaperone structures dissect molecular linkage between conformational asymmetry and sequential ATP hydrolysis.
Verkhivker GM
Biochim Biophys Acta Proteins Proteom; 2018 Aug; 1866(8):899-912. PubMed ID: 29684503
[TBL] [Abstract][Full Text] [Related]
12. The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting.
Masgras I; Laquatra C; Cannino G; Serapian SA; Colombo G; Rasola A
Semin Cancer Biol; 2021 Nov; 76():45-53. PubMed ID: 34242740
[TBL] [Abstract][Full Text] [Related]
13. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.
Kang BH
BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005
[TBL] [Abstract][Full Text] [Related]
14. The Structural Asymmetry of Mitochondrial Hsp90 (Trap1) Determines Fine Tuning of Functional Dynamics.
Moroni E; Agard DA; Colombo G
J Chem Theory Comput; 2018 Feb; 14(2):1033-1044. PubMed ID: 29320629
[TBL] [Abstract][Full Text] [Related]
15. Calcium binding to a remote site can replace magnesium as cofactor for mitochondrial Hsp90 (TRAP1) ATPase activity.
Elnatan D; Agard DA
J Biol Chem; 2018 Aug; 293(35):13717-13724. PubMed ID: 29991590
[TBL] [Abstract][Full Text] [Related]
16. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1.
Lee C; Park HK; Jeong H; Lim J; Lee AJ; Cheon KY; Kim CS; Thomas AP; Bae B; Kim ND; Kim SH; Suh PG; Ryu JH; Kang BH
J Am Chem Soc; 2015 Apr; 137(13):4358-67. PubMed ID: 25785725
[TBL] [Abstract][Full Text] [Related]
17. Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1.
Kang S; Kang BH
J Med Chem; 2022 Dec; 65(24):16155-16172. PubMed ID: 36507721
[TBL] [Abstract][Full Text] [Related]
18. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.
Landriscina M; Amoroso MR; Piscazzi A; Esposito F
Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270
[TBL] [Abstract][Full Text] [Related]
19. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties.
Felts SJ; Owen BA; Nguyen P; Trepel J; Donner DB; Toft DO
J Biol Chem; 2000 Feb; 275(5):3305-12. PubMed ID: 10652318
[TBL] [Abstract][Full Text] [Related]
20. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis.
Yoshida S; Tsutsumi S; Muhlebach G; Sourbier C; Lee MJ; Lee S; Vartholomaiou E; Tatokoro M; Beebe K; Miyajima N; Mohney RP; Chen Y; Hasumi H; Xu W; Fukushima H; Nakamura K; Koga F; Kihara K; Trepel J; Picard D; Neckers L
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):E1604-12. PubMed ID: 23564345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
